Bleichroeder LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.02B2026 Q3
Positions110
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.44.0%

Bleichroeder LP reported 110 positions worth $1.02B as of September 30, 2026 (13F filed November 13, 2026). Largest holding: GLD (17.8%). Biggest move: new buy PSQL ($22.2M).

10 / 110 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 GLDSPDR Gold$180.9M17.81%475,100——-6.7%
▸ 2 SPYSPDR S&P 500$51.6M5.08%67,645——-1.1%
▸ 3 GPGIGpgi$47.1M4.64%3,972,176——+17.5%
▸ 4 RHLDResolute Holdings Management$37.2M3.66%314,166——+26.0%
▸ 5 LINLinde$27.0M2.65%56,835——+10.8%
▸ 6 SPGIS&P Global$22.8M2.24%57,724——+20.1%
▸ 7 PSQLPasqal$22.2M2.19%3,496,313——-41.2%
▸ 8 AAgilent Technologies$20.9M2.06%121,265——+1.0%
▸ 9 TSMTaiwan Semiconductor$19.0M1.87%41,726——-12.6%
▸ 10 ENTGEntegris$18.4M1.81%119,549——-4.3%

Pro Feature

The remaining 100 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Bleichroeder LP hold as of Q3 2026?

Bleichroeder LP reported 110 positions worth $1.02B in its Q3 2026 13F filing. Largest positions: GLD (17.8%), SPY (5.1%), GPGI (4.6%), RHLD (3.7%) and LIN (2.7%).

What did Bleichroeder LP buy in Q3 2026?

New positions: PSQL, A, TSM, ENTG and ADI (38 in all). Added to: SPGI, MDXHEALTH SA, WELL, RANK ONE COMPUTING CORP and KAZIA THERAPEUTICS LTD (7 in all).

What did Bleichroeder LP sell in Q3 2026?

Reduced: IRD, LIN, PYPL, PROKIDNEY CORP and CUE BIOPHARMA INC (7 in all). Sold out entirely: CRIS1EUR, OWLET INC, 5E ADVANCED MATERIALS INC, EXMOC and BEYOND AIR INC (6 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.